Mergers and acquisitions are facing dual changing regulatory landscapes with respect to antitrust review and enforcement, and foreign investment into U.S. businesses under CFIUS. Both sets of changes represent aggressive tightening, make is more challenging to gain approval, and add costs and time to deals that ultimately do win clearance. New theories of harm being advanced under both regulatory regimes means having to evaluate new risks, and procedural changes under both regimes mea
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.97.14.85
Please verify email or join us to access premium content!